Results 221 to 230 of about 423,654 (332)

Glucagon‐like peptide‐1 receptor agonist and respiratory complications after endoscopy: A Japanese nationwide cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 316-323, January 2026.
Abstract Aims While discontinuation of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) before esophagogastroduodenoscopy (EGD) is not universally mandated, safety concerns persist. Evidence remains insufficient for managing specific patient subgroups, particularly in Asian populations. We aimed to provide evidence for stratified risk assessment in
Hiroyuki Hisada, Kazuhiko Ikeuchi, Yosuke Tsuji, Nobutake Yamamichi, Naomi Kakushima, Kazuya Okushin, Seiichi Yakabi, Chihiro Takeuchi, Daisuke Ohki, Hiroya Mizutani, Yuko Miura, Dai Kubota, Takeya Tsutsumi, Mitsuhiro Fujishiro   +13 more
wiley   +1 more source

Novel Curcumin Floating Tablets for Spatial Delivery in Peptic Ulcer. [PDF]

Biomed Res Int
Gupta C, Sahu GK, Parashar AK, Singh K, Bukke SPN, Udom GJ.   +5 more
europepmc   +1 more source

A comprehensive review on Peptic Ulcer Disease: Types, pathophysiology, diagnosis and treatment [PDF]

Priyanka G. Ghonge, Pooja R. Hatwar, Prashant G. Shelke, Ravindra L. Bakal, Sanika S. Khandare   +4 more
openalex   +1 more source

An Open‐Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7‐Day Triple Therapy With Bismuth Versus 14‐Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents

Helicobacter, Volume 31, Issue 1, January/February 2026.
ABSTRACT Background To achieve eradication rates > 90%, the ESPGHAN/NASPGHAN guidelines for pediatric Helicobacter pylori infection recommend tailored antimicrobial therapy using sufficiently high doses over 10–14 days. However, prolonged treatment often leads to suboptimal compliance in children, which is a major contributor to reduced eradication ...
Anja Šterbenc, Bor Vratanar, Eva Miler Mojškerc, Matjaž Homan   +3 more
wiley   +1 more source

Predictors of postoperative complications after surgery for perforated peptic ulcer: a prospective study from a tertiary center of Nepal. [PDF]

Ann Med Surg (Lond)
Koirala BH, Upadhya PS, Luitel P, Upreti S, Pokharel AN, Yadhav AP, Singh KN.   +6 more
europepmc   +1 more source

Dietary intakes and adipose tissue levels of linoleic acid in peptic ulcer disease [PDF]

, 1989
J. M. Kearney, Nicholas Kennedy, P. W. N. Keeling, J. J. Keating, Louise Grubb, Margaret Kennedy, Michael J. Gibney   +6 more
openalex   +1 more source

Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial

Helicobacter, Volume 31, Issue 1, January/February 2026.
ABSTRACT Background Tegoprazan, a potassium‐competitive acid blocker, offers potent and sustained acid inhibition and potentially improves eradication efficacy. Aim This study aimed to evaluate the efficacy and safety of tegoprazan‐based triple therapy with two dosing regimens compared with that of lansoprazole‐based therapy for first‐line Helicobacter
Jae Yong Park, Su Jin Hong, Il Ju Choi, Gwang Ho Baik, Sun Moon Kim, Jong‐Jae Park, Seong Woo Jeon, Kyung‐Oh Kim, Sang Kil Lee, Hwoon‐Yong Jung, Jung‐Hwan Oh, Chan Hyuk Park, Sang Wook Kim, Ki‐Nam Shim, Sam Ryong Jee, Hee Seok Moon, Jeong Seop Moon, Cheol Woong Choi, Wan‐Sik Lee, Jae Gyu Kim   +19 more
wiley   +1 more source

Antimicrobial resistance and virulence patterns of <i>Helicobacter pylori</i> among patients with suspected peptic ulcer disease in disenfranchised settings. [PDF]

Infect Med (Beijing)
Osman M, Rafei R, Cummings KJ, Rafei W, Awada J, Moubayed H, Majzoub F, Mallat H, Dabboussi F, Hamze M.   +9 more
europepmc   +1 more source

Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication ofHelicobacter pyloriin Chinese peptic ulcer patients

, 2005
Wei‐Hao Sun
openalex   +2 more sources

Risk Factors for Developing Peptic Ulcer Disease

, 2023
Martinez Glendy Alejandra
openalex   +2 more sources